整体素α6向瘤治疗药物
Xinling Li1,2, Kaili Xie1, Qiaoli Wang1
1State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060 P. R. China.
Phenomics (Cham, Switzerland)
|February 9, 2026
概括
集成蛋白α6 (α6) 探针对癌症治疗有希望. 一个alpha6向的SPECT探头是安全有效的乳腺癌检测,推进瘤成像和治疗.
科学领域:
- 在瘤学瘤学.
- 分子成像学分子成像学
- 生物标志物 生物标志物
背景情况:
- 整合素对于细胞粘附和信号传递至关重要,异常激活驱动癌症进展和治疗耐药性.
- 整合素α-vββ-3 (αvβ3) 已得到充分研究,但整合素α6 (α6) 子单元 (α6β1,α6β4) 越来越被认为是癌症的重要生物标志物.
- 综合素α6β1和α6β4的过度表达与各种癌症的预后不佳有关.
研究的目的:
- 审查最近在整合素α6向瘤治疗学方面的进展.
- 突出新型分子成像探针和针对整合素α6.6的治疗策略的开发和应用.
主要方法:
- 开发用于分子成像的多种整合素α6向探针,包括SPECT,PET,MRI和NIRF.
- 在首次在人类乳腺癌试点研究中对整合素α6向的SPECT探针进行临床评估.
- 设计和实施整合素α6向治疗策略.
主要成果:
- 一个针对整合素α6的SPECT探针在检测乳腺癌方面证明了安全性和有效性.
- 已经成功开发了各种成像探头 (SPECT,PET,MRI,NIRF) 用于整合素α6的可视化.
- 集成α6向疗法正在成为癌症治疗的有希望的方法.
结论:
- 集成素α6代表了癌症分子成像和治疗的显著疗效标.
- 集成α6向探针为早期癌症检测和个性化治疗提供了可行的策略.
- 对整合素α6疗效药物的持续研究有可能改善癌症患者的治疗结果.
相关概念视频
01:10Integrins
5.5K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.5K
01:15Activation of Integrins
5.2K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.2K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
02:17The Tumor Microenvironment
7.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K